Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.115673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Wanchen Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan; Graduate School of Medica…. Hauptthemen laut MEDLINE: Medulloblastoma, Chromatin, DNA-Binding Proteins, Cerebellar Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Nagoya City University, AMED.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan; Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8510, Jap…
- Cancer Cell Diversity Project, NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo 135-8550, Japan.
- Department of Medicine, University of California San Diego, La Jolla CA 92037, USA; Department of Neuro-oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Aichi 467-8601,…
- Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry (NCNP), Tokyo 187-8052, Japan.
- Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and Heidelberg University Hospital, 69120 Heidelberg, Germany.
- Department of Neuro-oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Aichi 467-8601, Japan.
Förderung
- Japan Society for the Promotion of Science
- Nagoya City University
- AMED
- National Center of Neurology and Psychiatry
- Uehara Memorial Foundation
- Brain Science Foundation
- Suzuken Memorial Foundation
- Tokyo Medical and Dental University
Zitieren
APA
Wang, W., Kumegawa, K., Chapman, O. S., Shiraishi, R., Xiao, Z., Okonechnikov, K., Sun, Y., Pfister, S. M., Feng, W., Uesaka, N., Hoshino, M., Takahashi, S., Korshunov, A., Chavez, L., Maruyama, R., & Kawauchi, D. (2025). Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. https://doi.org/10.1016/j.celrep.2025.115673
Vancouver
Wang W, Kumegawa K, Chapman OS, Shiraishi R, Xiao Z, Okonechnikov K, et al. Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. 2025. doi:10.1016/j.celrep.2025.115673
BibTeX
@article{Wang2025,
author = {Wang, Wanchen and Kumegawa, Kohei and Chapman, Owen S and Shiraishi, Ryo and Xiao, Zhize and Okonechnikov, Konstantin and Sun, Yang and Pfister, Stefan M and Feng, Weijun and Uesaka, Naofumi and Hoshino, Mikio and Takahashi, Satoru and Korshunov, Andrey and Chavez, Lukas and Maruyama, Reo and Kawauchi, Daisuke},
title = {Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.115673}
}
EUVIMED